Votes & Verdicts
Bloomberg
Votes and Verdicts is a series that examines the intersection of business, policy and law. It features conversations between Bloomberg Intelligence's team of litigation and policy analysts and thought leaders discussing legal and policy issues affecting markets and business decisions across many sectors.
Categories: Business
Listen to the last episode:
Closing arguments in the Justice Department’s antitrust case v. Google, a possible DOJ antitrust lawsuit against LiveNation and a key hearing for Lyft and Uber in California’s Supreme Court are important May catalysts to watch. This Bloomberg Intelligence litigation and policy outlook episode, hosted by financials litigation analyst Elliott Stein, gathered the team to discuss these and other developments. In addition, BNP Paribas and Societe Generale argued a Cuba sanctions case, while BNP tries to beat a Sudan genocide suit. The CFPB credit-card late-fee rule likely gets put on hold. They also examine a key Epic v. Apple hearing, possible regulatory action on bankers’ executive compensation, the DEA’s anticipated reclassification of marijuana and Congressional hearings focused on UnitedHealth.
See omnystudio.com/listener for privacy information.
Previous episodes
-
44 - Google, LiveNation, Uber and Other Catalysts Fri, 03 May 2024
-
43 - Kelleher on FinReg, ‘Kangaroo’ Courts Thu, 18 Apr 2024
-
42 - Pharma and Biotech Drug Pricing Policy Outlook Thu, 11 Apr 2024
-
41 - Antitrust Enforcers’ New Merger Guidelines Thu, 21 Mar 2024
-
40 - Eugene Scalia on Beating Regulators in Court Tue, 12 Mar 2024
-
39 - Market and Reimbursement Outlook for Cell and Gene Therapies Thu, 07 Mar 2024
-
38 - 3M, Synopsys, Capital One & Other Catalysts Fri, 01 Mar 2024
-
37 - Can Legal State Pot Put US Law Up in Smoke? Tue, 27 Feb 2024
-
36 - Biden’s Lab-Developed Test Proposal Tue, 20 Feb 2024
-
35 - Biden’s Drug-Pricing Expansion Plan, Part 2 Tue, 13 Feb 2024
-
34 - Apple, Bayer, Moderna and Other Catalysts Fri, 02 Feb 2024
-
33 - Apple’s Antitrust App-Store Battle With Epic Thu, 25 Jan 2024
-
32 - Washington’s Crowded Outlook for 2024 Tue, 23 Jan 2024
-
31 - Biden’s Drug Pricing March-in Proposal Thu, 18 Jan 2024
-
30 - Meta’s Biggest Legal, Regulatory Questions Mon, 18 Dec 2023
-
29 - Antitrust Changes Could Hinder M&A Mon, 11 Dec 2023
-
28 - Apple, Disney, Novo Nordisk, Other Catalysts Fri, 01 Dec 2023
-
27 - J&J, 3M's Chap 11 Play in Talc, Earplug Mass Torts Tue, 14 Nov 2023
-
26 - Berkshire, Google, Pega & Other Catalysts Fri, 03 Nov 2023
-
25 - Consumer Finance Impact of a CFPB Run Amok Tue, 31 Oct 2023
-
24 - Will IRA Drug Pricing Raise Employer Costs? Tue, 17 Oct 2023
-
23 - JJCI, Bayer, GSK, Mass Tort Litigation Risks Mon, 09 Oct 2023
-
22 - Bausch, GBTC, Merck, Meta & Other Catalysts Fri, 29 Sep 2023
-
21 - AI’s Biggest Legal and Regulatory Questions Tue, 26 Sep 2023
-
20 - FTC BioPharma M&A Approach Clashes With Sector Thu, 21 Sep 2023
-
19 - Likelihood Medicare Will Cover Obesity Drugs Tue, 05 Sep 2023
-
18 - 3M, Drug Pricing, Google and Other Catalysts Wed, 30 Aug 2023
-
17 - Can Anyone Defeat Trump? Insights on the Forthcoming GOP Debates Thu, 17 Aug 2023
-
16 - 3M, Google, Bank Rules, Other 2H Catalysts Fri, 21 Jul 2023
-
15 - Craig Burton on Inflation Reduction Act Wed, 19 Jul 2023
-
14 - Why PFAS Legal Risks Persist for 3M, Peers Thu, 13 Jul 2023
-
13 - Why a TikTok Ban Faces a Major Legal Hurdle Tue, 06 Jun 2023
-
12 - Catalysts to Watch – AI Laws, PFAS Trial Fri, 02 Jun 2023
-
11 - Adamantine’s Bays on Sustainable Investing Wed, 31 May 2023
-
10 - Margaux Hall on Drug Pricing Negotiation Wed, 24 May 2023
-
9 - Bill Hoagland on Debt-Ceiling Negotiations Mon, 15 May 2023
-
8 - Daniel Horwitz on Trump Indictment Strengths Mon, 15 May 2023
-
7 - Gottlieb on the Future of Crypto Policy, Law Mon, 15 May 2023
-
6 - The PFAS Problem, Regulatory and Other Issues Mon, 15 May 2023
-
5 - Crisis of Confidence, Regional Banks’ Future Mon, 15 May 2023
-
4 - The FTC’s Evolving Approach to Assessing M&A Mon, 15 May 2023
-
3 - The Biggest Tech-Regulation Questions Mon, 15 May 2023
-
2 - Energy's DC Opportunity, Risk with Schneider Mon, 15 May 2023
-
1 - Mulvaney on Crypto, the CFPB, and More Tue, 09 May 2023